Introduction {#sec1}
============

Chromenone motifs are valuable category of O-containing heterocycles that widely exist in nature, pharmaceutical agents, and synthetic intermediates.^[@ref1]^ Among the most significant subfamilies of chromenones, the amino substitution on the pyranone ring have attracted much attention recently, due to their potent effects in medicinal applications or clinical therapeutic effects. A particular example is 3-aminochromen-4-one, which has been reported to be cytotoxic active, and has the ability to inhibit cyclic AMP phosphodiesterase.^[@ref2]^ In addition, a series of 2- or 3-amino-substituted chromones have been identified to possess antiproliferative activities, antiviral and enzymatic inhibition,^[@ref3]^ and antirheumatic activities.^[@ref4]^ The 4-amino-substituted chromones have been recently recognized as a useful substrate to prepare bioactive chromeno\[4,3-*b*\]pyrrol-4(1*H*)-one derivatives.^[@ref5]^

To date, there are many methods including step-wise synthesis,^[@ref6]^ pyranone ring cyclizations,^[@ref7]^ and conjugate addition reactions,^[@ref8]^ which have been reported to effectively construct the chromone core structures. Although these approaches have been used frequently for the synthesis of chromone family members, they are not applicable for the synthesis of 2-imino-substituted or 2-amino-substituted chromenones. Recently, some new protocols have been successfully developed to prepare 2*H*-chromen-2-imines. For example, in 2011, Liu and Wang's group reported a microwave-assisted two-step synthesis of 2-iminocoumarin-3-carboxamide derivatives.^[@ref9]^ Later, Punniyamurthy developed a copper(I)-catalyzed one-pot synthesis of iminocoumarin aryl methyl ethers starting from ynal, phenol, and sulfonyl azide.^[@ref10]^ Li and co-workers described a straightforward path to the 2-aryliminochromene skeleton via a cascade three-component coupling reaction of arynes, *N*,*S*-keteneacetals, and dimethylformamide (DMF).^[@ref11]^ It should be noted that although these protocols have been frequently utilized in the synthesis of 2- or 3-amino-substituted coumarin derivatives, less attention has been focused on 4-amino-2*H*-chromen-2-imines, which have found noticeable applications in medicinal sciences and biological studies.^[@ref12]^

We were interested in developing novel domino reactions to construct combinatorial natural products like small organic molecules for the use in different biological assays.^[@ref13]^ A tandem-type cyclization that employs the first-row transition-metals is of particular interest because this would obviate the need for toxic and expensive heavy metal species. Our access to the amination of chromenone derivatives was inspired by the Cu-catalyzed regioselective Huisgen azide--alkyne cycloaddition (CuAAC) reaction of azides and terminal alkynes.^[@ref14]^ The key to the success of CuAAC is the in situ generation of a reactive ketenimine intermediate, which could be chemo- and regioselectively transformed into various heterocyclic molecules as disclosed by the groups of Chang and Wang,^[@ref15]^ and recently among others.^[@ref16]^ Copper-catalyzed tandem cyclization of ketenimine intermediates with different dipole nucleophile--electrophile building blocks such as 2-hydroxylacetophenones and 2-hydroxyphenylpropiolates has so far been explored to construct 2-iminocoumarins or similar fused O-heterocycles.^[@ref17]^ Recently, the Zhang and Yi's group reported an expedient synthesis of 4-amino-2*H*-chromen-2-imines by the combination of copper-catalyzed CuAAC reaction with 2-hydroxybenzonitriles.^[@ref18]^ The development of novel dipole nucleophile--electrophile building blocks for difunctionalization of the intermediate species can be expected, thus expanding the synthetic applications of useful cyclic molecules in step-economic domino reactions. Motivated by the pioneering works mentioned above, we herein present a novel Cu-catalyzed three-component cycloaddition reaction of benzo\[*d*\]isoxazole **1** with the in situ generated sulfonylketenimines from Huisgen azide--alkyne adducts, to produce functionalized 4-amino-4*H*-chromen-2-one imines **4** in good yields with excellent chemo- and regioselectivity.

Benzo\[*d*\]isoxazoles are readily available and stable substances, they have been recently employed to prepare various aza-heterocycles based on the nucleophilicity of the nitrogen atom in the molecule.^[@ref19]^ The Kemp elimination is a well-studied reaction in which a catalytic base abstracts a proton from the benzo\[*d*\]isoxazole ring, and thus results in ring-opening to form the cyanophenol product ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref20],[@ref21]^ Ever since its discovery, this protocol has been established as an important tool to develop conceptually innovative organocatalysis.^[@ref22]^ We envisioned that this anionic cyanophenol species could react with the highly reactive ketenimine species in suitable catalytic conditions through \[4 + 2\] cycloaddition process, thus giving the targeted 2-aminochromenone imines in a one-pot procedure. Interestingly, to our knowledge, there are currently very few reports to prepare O-heterocycles based on Kemp elimination process.

![Kemp Elimination Reaction and Its Application in the Synthesis of O-Containing Heterocycles](ao-2018-01179y_0006){#sch1}

Results and Discussion {#sec2}
======================

We first screened the reaction conditions in the copper-catalyzed three-component cyclization of benzo\[*d*\]isoxazole **1a** with tosyl azide **2a** and terminal alkyne **3a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). We supposed that the addition of base should be crucial for both of the desired Kemp elimination and triazole decomposition in this reaction. Indeed, when triethylamine (TEA) was added, the expected 4-amino-2*H*-chromen-2-imine **4a** was identified, albeit in very low yield at room temperature (entry 1). A brief screening of the copper catalyst, including Cu(I) and Cu(II) salts, indicated that CuBr gave a slightly improved yield of 21% (entries 2--5). Typically, the undesired Huisgen adduct **4a′** (10--15%),^[@ref14],[@ref23]^ and the remaining substrate **1a** (\>61%) accounted for the mass balance. The unusual slow conversion of this reaction was ascribed to the fact that the basic azaheterocycle **1a** can potentially deactivate the metal catalyst via coordination. In addition, the slow Kemp elimination of **1a** and the poor solubility of product **4a** should be taken into account. With these considerations in mind, we next raised the reaction temperature to a reflux condition of 80 °C in dichloroethane (DCE). Gratifyingly, a smooth reaction was observed to proceed for 4 h, the desired product **4a** was isolated in 74% yield (entry 6). A comparative result was observed when diisopropylethylamine (DIPEA) was employed (entry 7), whereas, the addition of other bases like K~2~CO~3~, pyridine, and 1,4-diazabicyclo\[2.2.2\]octane (DABCO) all failed to achieve any improvement, and worse yet the triazole **4a′** remained dominant in these cases (entries 8--10). The aims to reduce the loading of the copper catalyst and base gave no superior results, thus, 10 mol % of CuBr and 3.0 equiv of TEA were chosen as the optimal conditions for this three-component transformation (entries 11 and 12). Solvent screening indicated that modest yield was obtained in CHCl~3~, and no superior result was observed in 1,4-dioxane or toluene. It should be noted that complex results were observed in strong polar solvents like tetrahydrofuran (THF), DMF, and dimethyl sulfoxide (DMSO) (entries 13--18). Notably, a significant improvement in product formation was achieved when a mixture of organochlorine solvent was employed (entries 19--21). The expected product **4a** could be isolated in 89% yield in 0.1 M of DCE/dichloromethane (DCM) (1:1, v/v) system (entry 19).

###### Optimization of the Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-01179y_0003){#fx1}

  entry   cat. (*x*)        base (equiv)    solvent                 *T*/°C, *t*/h   yield (%)
  ------- ----------------- --------------- ----------------------- --------------- ------------------------------------
  1       CuI (10)          TEA (3)         DCE                     25, 12          19
  2       CuBr (10)         TEA (3)         DCE                     25, 12          21
  3       CuCl (10)         TEA (3)         DCE                     25, 12          13
  4       CuCN (10)         TEA (3)         DCE                     25, 24          5
  5       Cu(OTf)~2~ (10)   TEA (3)         DCE                     25, 12          17
  6       CuBr (10)         TEA (3)         DCE                     80, 4           74
  7       CuBr (10)         DIPEA (3)       DCE                     80, 4           69
  8       CuBr (10)         K~2~CO~3~ (3)   DCE                     80, 4           10
  9       CuBr (10)         Py (3)          DCE                     80, 4           0
  10      CuBr (10)         DABCO (3)       DCE                     80, 4           5
  11      CuBr (10)         TEA (2)         DCE                     80, 4           64
  12      CuBr (5)          TEA (3)         DCE                     80, 4           43
  13      CuBr (10)         TEA (3)         CHCl~3~                 80, 4           50
  14      CuBr (10)         TEA (3)         THF                     80, 4           0
  15      CuBr (10)         TEA (3)         1,4-dioxane             80, 4           22
  16      CuBr (10)         TEA (3)         toluene                 80, 4           22
  17      CuBr (10)         TEA (3)         DMF                     80, 4           trace
  18      CuBr (10)         TEA (3)         DMSO                    80, 4           0
  19      CuBr (10)         TEA (3)         DCE/DCM (1:1)           80, 4           89
  20      CuBr (10)         TEA (3)         DCE/CHCl~3~ (1:1)       80, 4           80
  21      CuBr (10)         TEA (3)         DCE/DCM (1:1) (0.5 M)   80, 4           84[b](#t1fn2){ref-type="table-fn"}

Reaction conditions: benzo\[*d*\]isoxazole **1a** (0.24 mmol), azide **2a** (0.40 mmol), and alkyne **3a** (0.20 mmol) in 2.0 mL of solvent under N~2~. Gas chromatography yield was estimated with naphthalene as an internal standard. Isolated yield in parentheses.

Solvent = 1.0 mL. DABCO = 1,4-diazabicyclo\[2.2.2\]octane.

The reaction scope for this convenient preparation of 4-amino-2*H*-chromen-2-imines **4** was next studied as presented in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. Employing benzo\[*d*\]isoxazole **1a** and tosyl azide **2a** as starting materials, the reactivity of various terminal alkynes **3** was evaluated. The aromatic alkynes that bear electron-donating functionalities (OMe, *n*Bu) at the para position of the phenyl ring participated in this three-component reaction smoothly, affording the corresponding products **3b** and **3d** in 68 and 96% yields, respectively. The structure of compound **4d** was verified unambiguously through X-ray crystallography analysis.^[@ref24]^ The synthetically useful halo-substituents such as fluoro (**4e**) and bromo (**4f**) groups were tolerated, which indicate that the further elaborations based on these synthetic handles can be applicable. The ester moiety attached on the phenyl ring of alkyne underwent the reaction smoothly to give product **4g** in moderate yield. In addition to these aryl terminal alkynes, the 3-thienyl heterocycle could also participate in this reaction, thus furnishing the bis-heterocyclic compound **4h** in 71% yield. A sluggish result of aliphatic alkyne **3i** with **1a** and **2a** was observed under the standard conditions. Fortunately, in modified reaction conditions, we found that when mixing tosyl azide **2a** with oct-1-yne **3i** in anhydrous DCE firstly under the catalysis of CuBr at room temperature, followed by the addition of benzo\[*d*\]isoxazole **1a** and TEA, the product **4i** could be successfully isolated at 80 °C in 62% yield. By utilizing this optimal procedure, the structurally strained cycloalkyl group could also be compatible, the reaction of **1a** and **2a** with ethynylcyclopropane afforded the expected product **4j** in 65% yield.

###### Substrate Scope for the Synthesis of **4**[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-01179y_0004){#fx2}

Reaction conditions: **1a** (0.24 mmol), **2a** (0.40 mmol), terminal alkyne **3** (0.20 mmol) in 2.0 mL of DCE at 80 °C. Isolated yield based on **3**.

Compound **2a** and alkyl alkyne **3** firstly reacted in DCE under the catalysis of CuBr for 1 h at room temperature, followed by the addition of substrate **1a** and TEA, the mixture was then stirred at 80 °C for an additional 4 h.

To further explore the synthetic utility of this diversity-oriented method for the synthesis of more complex O-heterocyclic imines **5**, we employed a variety of functionalized benzo\[*d*\]isoxazoles **1**, sulfonyl azides **2**, and terminal alkynes **3** in the reaction ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Substitution on the benzoid ring of benzo\[*d*\]isoxazoles **1** such as 5-methylbenzo\[*d*\]isoxazole or 5-chlorobenzo\[*d*\]isoxazole reacted with TsN~3~**2a** and 1-butyl-4-ethynylbenzene **3** under the catalysis of CuBr to afford the corresponding substituted 2-amino-4*H*-chromen-4-one imines **5a** and **5b** in 83 and 79% yields, respectively (entries 1 and 2). A smooth reaction was observed in the three-component reaction of 5-methylbenzo\[*d*\]isoxazole, 4-methoxybenzenesulfonyl azide, and 1-butyl-4-ethynylbenzene, the desired product **5c** was isolated in 95% yield (entry 3). The multicomponent cyclization reaction of 5-methoxybenzo\[*d*\]isoxazole with TsN~3~ and 1-butyl-4-ethynylbenzene gave the targeted product **5e** in 66% yield (entry 5). Interestingly, the result could be improved to 94% (**5f**) when 1-ethynyl-4-methoxybenzene was employed instead of 1-butyl-4-ethynylbenzene (entry 6). It seemed that the electron-rich aryl azides that bear electron-donating groups such as MeO or Me generally performed well compared to those of the electron-deficient ones (entries 1--4 vs 5--7). Indeed, when 4-bromobenzenesulfonyl azide was utilized as a nitrogen source of the ketenimine intermediate, the corresponding products **5h**, **5i**, and **5j** were produced in yields ranging from 59 to 67% (entries 8--10). The scope of the azide counterpart also turned out to be broad, the reaction of alkyl sulfonyl azide (MsN~3~) with various benzo\[*d*\]isoxazoles and aryl alkynes were readily employed with high efficiency and excellent chemical selectivity (entries 11--15). Other than the 5-substituted benzo\[*d*\]isoxazoles **1**, functional groups located at the other positions of the benzoid could be well tolerated in the reaction. For example, the reactions of 6-Me or 7-MeO-substituted benzo\[*d*\]isoxazole with TsN~3~ and aromatic alkynes successfully afforded the desired products **5p** and **5q** in moderate to good yields, respectively (entries 16--17). The 7-methoxybenzo\[*d*\]isoxazole reacted with MsN~3~ and 1-ethynyl-4-methoxybenzene smoothly to give compound **5r** in 47% yield (entry 18). In addition to these results, 4-chlorobenzo\[*d*\]isoxazole **1s** was found to react with TsN~3~ and an alkyl alkyne, hex-1-yne, to produce the desired product **5s** in 67% yield ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, eq 1).

![Extended Experiments](ao-2018-01179y_0001){#sch2}

###### Substrate Scope Studies[a](#t3fn1){ref-type="table-fn"}
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  entry   R^1^    R^2^            R^3^     yield (%)[a](#t3fn1){ref-type="table-fn"}
  ------- ------- --------------- -------- -------------------------------------------
  1       5-Me    4-MeC~6~H~4~    *n*Bu    83 (**5a**)
  2       5-Cl    4-MeC~6~H~4~    *n*Bu    79 (**5b**)
  3       5-Me    4-MeOC~6~H~4~   *n*Bu2   95 (**5c**)
  4       5-Me    C~6~H~5~        *n*Bu    88 (**5d**)
  5       5-MeO   4-ClC~6~H~4~    *n*Bu    66 (**5e**)
  6       5-MeO   4-ClC~6~H~4~    MeO      94 (**5f**)
  7       5-Me    4-ClC~6~H~4~    *n*Bu    73 (**5g**)
  8       5-Me    4-BrC~6~H~4~    Me       59 (**5h**)
  9       5-Me    4-BrC~6~H~4~    *n*Bu    67 (**5i**)
  10      5-Me    4-BrC~6~H~4~    F        62 (**5j**)
  11      5-Cl    Me              *n*Bu    56 (**5k**)
  12      H       Me              Me       76 (**5l**)
  13      5-Cl    Me              Me       98 (**5m**)
  14      5-Cl    Me              H        76 (**5n**)
  15      5-Cl    Me              F        84 (**5o**)
  16      6-Me    4-MeC~6~H~4~    *n*Bu    82 (**5p**)
  17      7-MeO   4-MeC~6~H~4~    H        43 (**5q**)
  18      7-MeO   Me              MeO      47 (**5r**)

Reaction conditions: benzo\[*d*\]isoxazole **1** (0.24 mmol), azide **2** (0.40 mmol), and terminal alkyne **3** (0.20 mmol) in 2.0 mL of DCE/DCM (v/v = 1:1) at 80 °C. Isolated yield of products **5** based on **3**.

We were pleased to observe that this copper-catalyzed three-component cyclization reaction could be easily enlarged to gram-scale, without the loss of catalytic efficiency and chemical selectivity. As can be seen in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, in the 5.0 mmol reaction of 1-butyl-4-ethynylbenzene **3a** with benzo\[*d*\]isoxazole **1a** and tosyl azide **2a**, the desired product **4a** could be isolated in 93% yield when 7.5 mol % of CuBr was employed as the catalyst ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, eq 2). On the other hand, with an aim to broaden the utility of the product, the Ts group was successfully removed to afford free 4-amino-3-arylcoumarins, whose analogues showed good antiarrhythmic activity, platelet antiaggregating activity and infiltration anesthesia activities in rats.^[@ref25]^ It was found that the treatment of compound **4a** with 5 N of H~2~SO~4~ in MeOH can give free 4-amino-3-arylchromen-2-one **7** in 78% yield. ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, eq 3).

Conclusions {#sec3}
===========

In conclusion, we have developed a copper-catalyzed multicomponent cascade cyclization reaction of benzo\[*d*\]isoxazoles with azides and terminal alkynes. The reaction proceeds through sequential azide--alkyne cycloaddition (CuAAC)/Kemp elimination/tandem cyclization, thus providing efficient access to diversity-oriented O-heterocycles 4-amino-2*H*-chromenone-2-imines. The reaction tolerated a broad range of functional groups, and only released N~2~ as the sole byproduct. Moreover, the reaction could be easily extended to gram-scale and the afforded product could be converted into medicinally active free 4-amino-2*H*-chromen-2-one in good yield.

Experimental Section {#sec4}
====================

Unless otherwise noted, commercial reagents were purchased from Aldrich, Alfa Aesar, or other commercial suppliers, and were used as received. Solvents were dried and distilled according to standard procedures before use. Reactions were conducted using standard Schlenk techniques on a vacuum line. Analytical thin-layer chromatography (TLC) was performed using glass plates precoated with 0.25 mm 230--400 mesh silica gel impregnated with a fluorescent indicator (254 nm). Flash column chromatography was performed using a silica gel (60 Å pore size, 32--63 μm, standard grade). Organic solutions were concentrated on rotary evaporators at ∼20 Torr (house vacuum) at 25--35 °C. NMR spectra are recorded in parts per million (ppm) from internal standard tetramethylsilane on the δ scale. High-resolution mass spectrometry (HRMS) analysis was performed by electrospray ionization (ESI-micrOTOF).

General Procedure for the Preparation of 2-Imino-2*H*-chromen-4-amines **4** and **5** {#sec4.1}
--------------------------------------------------------------------------------------

Sulfonyl azide **2** (0.30 mmol, 1.5 equiv), terminal alkyne **3** (0.20 mmol, 1.0 equiv), CuBr (0.02 mmol, 10 mol %), and benzo\[*d*\]isoxazole **1** (0.30 mmol, 1.5 equiv) were added to a solution of anhydrous solvent mixture of DCE/DCM (2.0 mL, v/v = 1:1) at room temperature under N~2~. Then triethylamine (0.60 mmol, 3.0 equiv) was slowly added by a syringe. The reaction was stirred at 80 °C for about 2--4 h. After completion of the reaction as indicated by TLC, the reaction mixture was quenched with saturated NH~4~Cl solution (3.0 mL), and extracted with ethyl acetate (3.0 mL × 3). The combined organic layer was dried over Na~2~SO~4~, filtered, and concentrated. The crude residue was purified by flash column chromatograph (EtOA/DCM = 1:20, or recrystallization) to give the desired products **4** or **5**.

### *N*-(4-Amino-3-(*p*-tolyl)-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4a**) {#sec4.1.1}

Yield: 89%; white solid, mp: 270--271 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.26 (d, *J* = 7.9 Hz, 1H), 7.81 (d, *J* = 7.9 Hz, 2H), 7.70 (t, *J* = 7.7 Hz, 1H), 7.43 (t, *J* = 8.9 Hz, 2H), 7.33--7.30 (m, 4H), 7.16 (d, *J* = 7.7 Hz, 2H), 2.38 (s, 3H), 2.32 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.3, 152.7, 152.0, 142.0, 141.7, 137.3, 133.5, 131.4, 130.0, 129.9, 129.5, 127.3, 125.6, 124.4, 116.9, 114.7, 99.9, 21.5, 21.4. HRMS calcd for C~23~H~21~N~2~O~3~S (M + H)^+^: 405.1273, found: 405.1267.

### *N*-(4-Amino-3-(4-methoxyphenyl)-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4b**) {#sec4.1.2}

Yield: 68%; white solid, mp: 218--219 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.18 (d, *J* = 8.0 Hz, 1H), 7.74 (d, *J* = 8.0 Hz, 2H), 7.62 (t, *J* = 7.7 Hz, 1H), 7.38--7.33 (m, 2H), 7.25 (d, *J* = 8.0 Hz, 2H), 7.12 (d, *J* = 8.5 Hz, 2H), 6.99 (d, *J* = 8.5 Hz, 2H), 3.75 (s, 3H), 2.25 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.4, 159.2, 152.9, 152.0, 142.0, 141.7, 133.4, 132.7, 129.5, 127.3, 125.6, 124.8, 124.4, 116.9, 115.0, 114.7, 99.7, 55.5, 21.4. HRMS calcd for C~23~H~21~N~2~O~4~S (M + H)^+^: 421.1222, found: 421.1217.

### *N*-(4-Amino-3-phenyl-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4c**) {#sec4.1.3}

Yield: 68%; white solid, mp: 261--262 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.31 (t, *J* = 9.8 Hz, 1H), 7.85 (d, *J* = 8.1 Hz, 2H), 7.72 (t, *J* = 7.7 Hz, 1H), 7.53 (t, *J* = 7.4 Hz, 2H), 7.47--7.41 (m, 3H), 7.34--7.21 (m, 4H), 2.32 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.2, 152.7, 152.0, 142.0, 141.7, 133.6, 133.0, 131.6, 129.5, 128.2, 127.3, 125.7, 124.5, 117.0, 114.7, 100.0, 21.4. HRMS calcd for C~22~H~19~N~2~O~3~S (M + H)^+^: 391.1116, found: 391.1111.

### *N*-(4-Amino-3-(4-butylphenyl)-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4d**) {#sec4.1.4}

Yield: 96%; white solid, mp: 92--93 °C. ^1^H NMR (400 MHz, CDCl~3~) δ: 7.84 (d, *J* = 8.1 Hz, 2H), 7.74 (d, *J* = 7.9 Hz, 1H), 7.44 (t, *J* = 7.7 Hz, 1H), 7.21--7.18 (m, 3H), 7.14--7.10 (m, 5H), 6.02--5.75 (br, 2H), 2.52 (t, *J* = 7.7 Hz, 2H), 2.34 (s, 3H), 1.56--1.52 (m, 2H), 1.38--1.26 (m, 2H), 0.91 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ: 159.6, 152.0, 151.6, 143.0, 142.1, 140.9, 132.3, 130.5, 129.3, 129.0, 128.7, 126.9, 125.0, 123.1, 116.8, 114.0, 101.4, 35.4, 33.4, 22.4, 21.5, 14.0. HRMS calcd for C~26~H~27~N~2~O~3~S (M + H)^+^: 447.1742, found: 447.1737.

### *N*-(4-Amino-3-(4-fluorophenyl)-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4e**) {#sec4.1.5}

Yield: 71%; white solid, mp: 301--302 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.26 (d, *J* = 6.0 Hz, 1H), 7.82 (d, *J* = 5.4 Hz, 2H), 7.70 (d, *J* = 6.7 Hz, 1H), 7.44--7.41 (m, 2H), 7.38--7.02 (m, 6H), 2.32 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 162.3 (d, ^1^*J* = 243 Hz), 159.2, 153.0, 152.0, 142.0, 141.7, 133.8, 133.7, 133.6, 129.5, 129.2, 127.3, 125.7, 124.4, 116.5, 116.3 (d, ^2^*J* = 21 Hz), 114.7 (d, ^2^*J* = 23 Hz), 99.0, 21.4. HRMS calcd for C~22~H~18~FN~2~O~3~S (M + H)^+^: 409.1022, found: 409.1017.

### *N*-(4-Amino-3-(4-bromophenyl)-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4f**) {#sec4.1.6}

Yield: 53%; yellow solid, mp: 284--285 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.25 (d, *J* = 8.0 Hz, 1H), 7.88--7.56 (m, 5H), 7.43--7.25 (m, 6H), 2.32 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.0, 152.8, 152.0, 142.1, 141.6, 133.9, 133.6, 132.4, 129.5, 128.5, 127.3, 125.7, 124.4, 121.7, 117.0, 114.7, 98.8, 21.4. HRMS calcd for C~22~H~18~BrN~2~O~3~S (M + H)^+^: 469.0222, found: 469.0216.

### Methyl-4-(4-amino-2-(tosylimino)-2*H*-chromen-3-yl)benzoate (**4g**) {#sec4.1.7}

Yield: 40%; white solid, mp: 268--269 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.27 (d, *J* = 8.0 Hz, 1H), 8.07 (d, *J* = 8.1 Hz, 2H), 7.81 (d, *J* = 8.1 Hz, 2H), 7.72 (t, *J* = 7.8 Hz, 1H), 7.48--7.43 (m, 4H), 7.32 (d, *J* = 8.0 Hz, 2H), 3.90 (s, 3H), 2.32 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 166.7, 158.8, 152.8, 152.1, 142.1, 141.6, 138.4, 133.7, 132.2, 130.3, 129.5, 129.3, 127.3, 125.7, 124.5, 117.1, 114.6, 98.9, 52.77, 21.4. HRMS calcd for C~24~H~21~N~2~O~5~S (M + H)^+^: 449.1171, found: 449.1166.

### *N*-(4-Amino-3-(thiophen-3-yl)-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4h**) {#sec4.1.8}

Yield: 71%; yellow solid, mp: 246--247 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.27 (d, *J* = 8.0 Hz, 1H), 7.84 (d, *J* = 8.0 Hz, 2H), 7.75--7.64 (m, 2H), 7.55 (d, *J* = 1.6 Hz, 1H), 7.72--7.66 (m, 2H), 7.32 (d, *J* = 8.0 Hz, 2H), 7.12 (d, *J* = 4.8 Hz, 1H), 2.33 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 158.9, 153.0, 151.8, 142.0, 141.7, 133.6, 132.1, 130.3, 129.5, 127.3, 126.6, 126.4, 125.7, 124.4, 117.1, 114.5, 95.0, 21.4. HRMS calcd for C~20~H~17~N~2~O~3~S~2~ (M + H)^+^: 397.0681, found: 397.0675.

### *N*-(4-Amino-3-hexyl-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**4i**) {#sec4.1.9}

Yield: 62%; white solid, mp: 188--189 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.15 (d, *J* = 8.1 Hz, 1H), 7.85 (d, *J* = 7.5 Hz, 2H), 7.64 (t, *J* = 7.8 Hz, 1H), 7.47--7.29 (m, 4H), 2.49 (d, *J* = 8.2 Hz, 2H), 2.31 (s, 3H), 1.40--1.25 (m, 8H), 0.84 (t, *J* = 6.2 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.7, 151.9, 151.6, 141.9, 132.8, 129.4, 127.2, 125.4, 123.7, 116.9, 114.8, 98.7, 31.8, 28.9, 27.1, 24.2, 22.6, 21.4, 14.4. HRMS calcd for C~22~H~27~N~2~O~3~S (M + H)^+^: 399.1742, found: 399.1737.

### *N*-(4-Amino-3-cyclopropyl-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide(**4j**) {#sec4.1.10}

Yield: 65%; white solid, mp: 242--243 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.18 (d, *J* = 8.0 Hz, 1H), 7.86 (d, *J* = 7.8 Hz, 2H), 7.64 (t, *J* = 7.8 Hz, 1H), 7.40 (t, *J* = 7.6 Hz, 1H), 7.33 (t, *J* = 7.6 Hz, 3H), 2.32 (s, 3H), 1.32--1.30 (m, 1H), 1.00 (d, *J* = 7.0 Hz, 2H), 0.54 (d, *J* = 4.7 Hz, 2H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.8, 154.5, 151.8, 142.0, 141.8, 132.9, 129.4, 127.2, 125.4, 123.8, 116.8, 114.75, 97.7, 21.4, 8.8, 6.6. HRMS calcd for C~19~H~19~N~2~O~3~S (M + H)^+^: 355.1116, found: 355.1111.

### *N*-(4-Amino-3-(4-butylphenyl)-6-methyl-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**5a**) {#sec4.1.11}

Yield: 83%; white solid, mp: 210--211 °C. ^1^H NMR (400 MHz, CDCl~3~) δ: 7.85 (d, *J* = 8.2 Hz, 2H), 7.54 (s, 1H), 7.27 (d, *J* = 8.2 Hz, 1H), 7.17 (d, *J* = 8.1 Hz, 2H), 7.12 (d, *J* = 8.5 Hz, 1H), 7.17--6.96 (m, 4H), 5.90--7.76 (br, 2H), 2.49 (t, *J* = 7.7 Hz, 2H), 2.33 (s, 3H), 2.25 (s, 3H), 1.54--1.50 (m, 2H), 1.35--1.30 (m, 2H), 0.91 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ: 159.7, 151.6, 150.3, 142.8, 141.9, 141.0, 135.0, 133.5, 130.5, 129.2, 128.9, 128.8, 127.0, 122.8, 116.5, 113.7, 101.4, 35.4, 33.4, 22.4, 21.4, 20.9, 14.0. HRMS calcd for C~27~H~29~N~2~O~3~S (M + H)^+^: 461.1899, found: 461.1893.

### *N*-(4-Amino-3-(4-butylphenyl)-6-chloro-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**5b**) {#sec4.1.12}

Yield: 79%; white solid, mp: 229--230 °C. ^1^H NMR (400 MHz, CDCl~3~) δ: 7.87 (d, *J* = 8.1 Hz, 2H), 7.73 (d, *J* = 1.8 Hz, 1H), 7.43 (dd, *J* = 8.8, 1.9 Hz, 1H), 7.22--7.20 (m, 3H), 7.12--7.01 (m, 4H), 5.92--5.74 (br, 2H), 2.44 (t, *J* = 7.6 Hz, 2H), 2.35 (s, 3H), 1.53--1.45 (m, 2H), 1.35--1.26 (m, 2H), 0.90 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ: 159.3, 150.5, 150.5, 143.2, 142.3, 140.5, 132.3, 130.5, 130.3, 129.3, 129.0, 128.3, 127.1, 123.1, 118.2, 115.3, 101.9, 35.3, 33.4, 22.3, 21.5, 14.0. HRMS calcd for C~26~H~26~ClN~2~O~3~S (M + H)^+^: 481.1353, found: 481.1347.

### *N*-(4-Amino-3-(4-butylphenyl)-6-methyl-2*H*-chromen-2-ylidene)-4-methoxybenzenesulfonamide (**5c**) {#sec4.1.13}

Yield: 95%; white solid, mp: 198--199 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.11 (s, 1H), 7.86 (d, *J* = 8.7 Hz, 2H), 7.51 (d, *J* = 8.4 Hz, 1H), 7.35--7.30 (m, 3H), 7.17 (d, *J* = 7.8 Hz, 2H), 7.03 (d, *J* = 8.7 Hz, 2H), 3.78 (s, 3H), 2.64 (t, *J* = 7.7 Hz, 2H), 2.38 (s, 3H), 1.67--1.60 (m, 2H), 1.42--1.36 (m, 2H), 0.94 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 161.9, 159.2, 152.5, 150.2, 142.1, 136.5, 135.0, 134.2, 131.3, 130.2, 129.3, 124.0, 116.7, 114.3, 114.1, 99.9, 55.9, 35.3, 33.4, 22.5, 21.0, 14.3. HRMS calcd for C~27~H~28~N~2~O~4~SNa (M + Na)^+^: 499.1667, found: 499.1662.

### *N*-(4-Amino-3-(4-butylphenyl)-6-methyl-2*H*-chromen-2-ylidene)benzenesulfonamide (**5d**) {#sec4.1.14}

Yield: 88%; white solid, mp: 105--106 °C. ^1^H NMR (400 MHz, CDCl~3~) δ: 7.96 (d, *J* = 7.0 Hz, 2H), 7.54 (s, 1H), 7.42--7.37 (m, 3H), 7.27 (d, *J* = 9.0 Hz, 1H), 7.20--7.04 (m, 5H), 6.02--5.78 (br, 2H), 2.51 (t, *J* = 7.6 Hz, 2H), 2.26 (s, 3H), 1.55--1.52 (m, 2H), 1.36--1.31 (m, 2H), 0.91 (t, *J* = 7.2 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ: 159.8, 151.6, 150.3, 143.9, 142.9, 135.1, 133.6, 131.5, 130.5, 129.2, 128.7, 128.3, 126.9, 122.7, 116.6, 113.6, 101.5, 35.4, 33.4, 22.4, 20.9, 14.0. HRMS calcd for C~26~H~26~N~2~O~3~SNa (M + Na)^+^: 469.1562, found: 469.1556.

### *N*-(4-Amino-3-(4-butylphenyl)-6-methoxy-2*H*-chromen-2-ylidene)-4-chlorobenzenesulfonamide (**5e**) {#sec4.1.15}

Yield: 66%; white solid, mp: 267--268 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.21 (d, *J* = 9.0 Hz, 1H), 7.94 (d, *J* = 8.3 Hz, 2H), 7.58 (d, *J* = 8.3 Hz, 2H), 7.30 (d, *J* = 7.6 Hz, 2H), 7.17 (d, *J* = 7.7 Hz, 2H), 7.06 (d, *J* = 8.0 Hz, 1H), 6.84 (s, 1H), 3.92 (s, 3H), 2.63 (t, *J* = 7.5 Hz, 2H), 1.66--1.59 (m, 2H), 1.41--1.33 (m, 2H), 0.94 (t, *J* = 7.2 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 163.5, 159.5, 153.8, 153.5, 143.7, 142.1, 136.6, 131.5, 120.0, 129.3, 129.1, 125.9, 114.1, 107.7, 100.3, 98.4, 56.7, 35.3, 33.4, 22.5, 14.3. HRMS calcd for C~26~H~26~ClN~2~O~4~S (M + H)^+^: 497.1302, found: 497.1296.

### *N*-(4-Amino-6-methoxy-3-(4-methoxyphenyl)-2*H*-chromen-2-ylidene)-4-chlorobenzenesulfonamide (**5f**) {#sec4.1.16}

Yield: 94%; white solid, mp: 237--238 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.19 (d, *J* = 9.0 Hz, 1H), 7.95 (d, *J* = 8.5 Hz, 2H), 7.59 (d, *J* = 8.5 Hz, 2H), 7.18 (d, *J* = 8.5 Hz, 2H), 7.10--6.95 (m, 3H), 6.83 (d, *J* = 2.1 Hz, 1H), 3.92 (s, 3H), 3.82 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 163.4, 159.6, 159.2, 153.7, 143.7, 136.6, 132.8, 129.3, 129.1, 125.9, 124.7, 114.9, 114.0, 107.8, 100.3, 98.2, 56.6, 55.5. HRMS calcd for C~23~H~20~ClN~2~O~5~S (M + H)^+^: 471.0781, found: 471.0776.

### *N*-(4-Amino-3-(4-butylphenyl)-6-methyl-2*H*-chromen-2-ylidene)-4-chlorobenzenesulfonamide (**5g**) {#sec4.1.17}

Yield: 73%; white solid, mp: 219--220 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.31 (s, 1H), 8.09 (d, *J* = 8.0 Hz, 1H), 7.91 (d, *J* = 8.3 Hz, 2H), 7.58--7.52 (m, 3H), 7.34--7.30 (m, 2H), 7.18 (d, *J* = 7.7 Hz, 2H), 2.64 (t, *J* = 7.6 Hz, 2H), 2.39 (s, 3H), 1.67--1.60 (m, 2H), 1.43--1.36 (m, 2H), 0.94 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.6, 153.2, 150.2, 143.6, 142.2, 136.6, 135.3, 134.5, 131.3, 130.0, 129.4, 129.2, 129.1, 124.1, 116.7, 114.3, 100.0, 35.3, 33.4, 22.4, 21.0, 14.3. HRMS calcd for C~26~H~25~ClN~2~O~3~SNa (M + Na)^+^: 503.1172, found: 503.1167.

### *N*-(4-Amino-6-methyl-3-(*p*-tolyl)-2*H*-chromen-2-ylidene)-4-bromobenzenesulfonamide (**5h**) {#sec4.1.18}

Yield: 59%; yellow solid, mp: 281--282 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.12 (s, 1H), 7.85 (d, *J* = 8.4 Hz, 2H), 7.72 (d, *J* = 8.4 Hz, 2H), 7.52 (d, *J* = 8.5 Hz, 1H), 7.35--7.29 (m, 3H), 7.16 (d, *J* = 7.8 Hz, 2H), 2.38 (s, 6H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.6, 153.2, 150.2, 144.0, 137.4, 135.3, 134.5, 132.1, 131.4, 130.1, 129.8, 129.4, 125.5, 124.1, 116.7, 114.3, 100.0, 21.4, 21.0. HRMS calcd for C~23~H~20~BrN~2~O~3~S (M + H)^+^: 483.0378, found: 483.0373.

### *N*-(4-Amino-3-(4-butylphenyl)-6-methyl-2*H*-chromen-2-ylidene)-4-bromobenzenesulfonamide (**5i**) {#sec4.1.19}

Yield: 67%; yellow solid, mp: 221--222 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.13 (s, 1H), 7.84 (d, *J* = 8.3 Hz, 2H), 7.71 (d, *J* = 8.4 Hz, 2H), 7.53 (d, *J* = 8.4 Hz, 1H), 7.34--7.30 (m, 3H), 7.18 (d, *J* = 7.8 Hz, 2H), 2.64 (t, *J* = 7.6 Hz, 2H), 2.39 (s, 3H), 1.66--1.62 (m, 2H), 1.42--1.36 (m, 2H), 0.95 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.6, 153.2, 150.2, 144.0, 142.2, 135.3, 134.5, 132.1, 131.3, 123.0, 129.4, 125.5, 124.1, 116.7, 114.3, 100.0, 35.3, 33.4, 22.4, 21.0, 14.3. HRMS calcd for C~26~H~26~BrN~2~O~3~S (M + H)^+^: 525.0848, found: 525.0842.

### *N*-(4-Amino-3-(4-fluorophenyl)-6-methyl-2*H*-chromen-2-ylidene)-4-bromobenzenesulfonamide (**5j**) {#sec4.1.20}

Yield: 62%; yellow solid, mp: 278--279 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.12 (s, 1H), 7.85 (d, *J* = 8.5 Hz, 2H), 7.72 (d, *J* = 8.5 Hz, 2H), 7.54 (d, *J* = 8.5 Hz, 1H), 7.36--7.31 (m, 5H), 2.39 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 162.5 (d, ^1^*J* = 243 Hz), 159.5, 153.5, 150.3, 143.9, 135.3, 134.6, 133.8, 133.7, 132.1, 129.4, 124.9 (d, ^2^*J* = 23 Hz), 116.7, 116.3 (d, ^2^*J* = 21 Hz), 114.3, 100.0, 99.1, 21.0. HRMS calcd for C~22~H~17~BrFN~2~O~3~S (M + H)^+^: 487.0127, found: 487.0122.

### *N*-(4-Amino-3-(4-butylphenyl)-6-chloro-2*H*-chromen-2-ylidene)methanesulfonamide (**5k**) {#sec4.1.21}

Yield: 56%; white solid, mp: 210--211 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.48 (s, 1H), 7.77 (d, *J* = 8.8 Hz, 1H), 7.61 (d, *J* = 8.9 Hz, 1H), 7.30 (d, *J* = 7.7 Hz, 2H), 7.20 (d, *J* = 7.7 Hz, 2H), 3.00 (s, 3H), 2.63 (t, *J* = 7.6 Hz, 2H), 1.67--1.59 (m, 2H), 1.41--1.36 (m, 2H), 0.94 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.1, 151.3, 150.7, 142.2, 132.9, 131.2, 130.0, 129.8, 129.3, 123.9, 119.4, 116.4, 100.2, 43.0, 35.3, 33.4, 22.5, 14.3. HRMS calcd for C~20~H~22~ClN~2~O~3~S (M + H)^+^: 405.1040, found: 405.1034.

### *N*-(4-Amino-3-(*p*-tolyl)-2*H*-chromen-2-ylidene)methanesulfonamide (**5l**) {#sec4.1.22}

Yield 76%; white solid, mp: 214--215 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.30 (d, *J* = 8.1 Hz, 1H), 7.74 (t, *J* = 7.7 Hz, 1H), 7.56 (d, *J* = 8.3 Hz, 1H), 7.48 (t, *J* = 7.6 Hz, 1H), 7.30 (d, *J* = 7.8 Hz, 2H), 7.19 (d, *J* = 7.8 Hz, 2H), 2.99 (s, 3H), 2.38 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.5, 152.3, 152.1, 137.2, 133.3, 131.4, 130.0, 125.6, 124.3, 117.4, 114.8, 99.7, 79.7, 43.0, 21.4. HRMS calcd for C~17~H~17~N~2~O~3~S (M + H)^+^: 329.0960, found: 329.0954.

### *N*-(4-Amino-6-chloro-3-(*p*-tolyl)-2*H*-chromen-2-ylidene)methanesulfonamide (**5m**) {#sec4.1.23}

Yield: 98%; white solid, mp: 286--287 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.47 (d, *J* = 2.1 Hz, 1H), 7.78--7.75 (m, 1H), 7.60 (d, *J* = 8.9 Hz, 1H), 7.29 (d, *J* = 7.9 Hz, 2H), 7.18 (d, *J* = 7.9 Hz, 2H), 2.99 (s, 3H), 2.37 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.1, 151.3, 150.7, 137.3, 132.9, 131.3, 130.0, 129.8, 123.9, 119.4, 116.4, 100.2, 43.0, 21.4. HRMS calcd for C~17~H~16~ClN~2~O~3~S (M + H)^+^: 363.0570, found: 363.0565.

### *N*-(4-Amino-6-chloro-3-phenyl-2*H*-chromen-2-ylidene)methanesulfonamide (**5n**) {#sec4.1.24}

Yield: 76%; white solid, mp: 230--231 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.48 (d, *J* = 2.1 Hz, 1H), 8.32 (s, 1H), 7.79--7.76 (m, 1H), 7.61 (d, *J* = 8.9 Hz, 1H), 7.49 (t, *J* = 7.5 Hz, 2H), 7.40 (t, *J* = 7.3 Hz, 1H), 7.30 (d, *J* = 7.3 Hz, 1H), 2.99 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.0, 151.2, 150.8, 133.0, 132.8, 131.5, 129.8, 129.4, 128.2, 123.9, 119.4, 116.4, 100.3, 79.7, 43.0. HRMS calcd for C~16~H~14~ClN~2~O~3~S (M + H)^+^: 349.0414, found: 349.0408.

### *N*-(4-Amino-6-chloro-3-(4-fluorophenyl)-2*H*-chromen-2-ylidene)methanesulfonamide (**5o**) {#sec4.1.25}

Yield: 84%; white solid, mp: 268--269 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.46 (s, 1H), 8.32 (s, 1H), 7.77 (d, *J* = 8.1 Hz, 1H), 7.61 (d, *J* = 8.7 Hz, 1H), 7.42--7.25 (m, 3H), 2.99 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 162.2 (d, ^1^*J* = 243 Hz), 159.0, 151.6, 150.8, 133.7, 133.6, 129.8, 129.1, 123.9, 119.5, 116.3 (d, ^2^*J* = 21 Hz), 99.3, 79.8, 43.0. HRMS calcd for C~16~H~13~ClFN~2~O~3~S (M + H)^+^: 367.0319, found: 367.0314.

### *N*-(4-Amino-3-(4-butylphenyl)-7-methyl-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**5p**) {#sec4.1.26}

Yield: 82%; white solid, mp: 109--110 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 8.14 (d, *J* = 8.6 Hz, 1H), 7.80 (d, *J* = 8.0 Hz, 2H), 7.33--7.26 (m, 6H), 7.18 (d, *J* = 7.9 Hz, 2H), 5.75 (br, 2H), 2.65 (t, *J* = 7.7 Hz, 2H), 2.46 (s, 3H), 2.33 (s, 3H), 1.67--1.63 (m, 2H), 1.42--1.37 (m, 2H), 0.95 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.4, 152.8, 152.1, 144.4, 142.1, 141.9, 131.4, 130.1, 129.4, 129.3, 127.2, 126.8, 124.2, 116.8, 112.2, 99.4, 35.3, 33.4, 22.4, 21.5, 21.4, 14.3. HRMS calcd for C~27~H~29~N~2~O~3~S (M+H)^+^: 461.1893, found: 461.1899.

### *N*-(4-Amino-8-methoxy-3-phenyl-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**5q**) {#sec4.1.27}

Yield: 43%; white solid, mp: \>320 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 7.89 (d, *J* = 8.0 Hz, 2H), 7.80--7.78 (m, 1H), 7.53--7.47 (m, 2H), 7.43--7.37 (m, 3H), 7.29--7.23 (m, 4H), 4.02 (s, 3H), 2.33 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 158.8, 152.8, 147.9, 142.3, 141.8, 141.2, 133.1, 131.5, 129.5, 129.0, 128.2, 127.7, 125.5, 115.6, 115.4, 115.0, 100.4, 56.8, 21.4. HRMS calcd for C~23~H~21~N~2~O~4~S (M + H)^+^: 421.1217, found: 421.1219.

### *N*-(4-Amino-8-methoxy-3-(4-methoxyphenyl)-2*H*-chromen-2-ylidene)methanesulfonamide (**5r**) {#sec4.1.28}

Yield: 47%; white solid, mp: 227--228 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 7.84--7.82 (m, *J* = 6.4, 2.6 Hz, 1H), 7.40 (d, *J* = 6.4 Hz, 2H), 7.21 (d, *J* = 8.5 Hz, 2H), 7.05 (d, *J* = 8.5 Hz, 2H), 3.97 (s, 3H), 3.82 (s, 3H), 3.15 (s, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 159.2, 159.0, 152.8, 147.9, 142.2, 132.7, 125.4, 124.9, 115.7, 115.3, 115.2, 114.9, 99.5, 57.2, 55.6, 42.6. HRMS calcd for C~18~H~19~N~2~O~5~S (M + H)^+^: 375.1009, found: 375.1012.

### *N*-(4-Amino-3-butyl-5-chloro-2*H*-chromen-2-ylidene)-4-methylbenzenesulfonamide (**5s**) {#sec4.1.29}

Yield: 67%; white solid, mp: 181--182 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ: 7.85 (d, *J* = 8.1 Hz, 2H), 7.62 (br, 2H), 7.58 (d, *J* = 8.2 Hz, 1H), 7.47 (d, *J* = 7.7 Hz, 1H), 7.36--7.32 (m, 3H), 2.33 (s, 3H), 1.40--1.31 (m, 6H), 0.90 (t, *J* = 6.6 Hz, 3H). ^13^C NMR (100 MHz, DMSO-*d*~6~) δ: 158.4, 153.3, 151.2, 142.1, 141.6, 132.8, 129.5, 129.5, 128.9, 127.1, 117.1, 112.2, 100.3, 28.9, 24.0, 22.4, 21.4, 14.5. HRMS calcd for C~20~H~22~ClN~2~O~3~S (M + H)^+^: 405.1034, found: 405.1039.

Gram-Scale Synthesis of Compound **4a** {#sec4.2}
---------------------------------------

Tosyl azide **2a** (TsN~3~, 7.5 mmol, 1.5 equiv), 1-butyl-4-ethynylbenzene **3a** (5 mmol, 1.0 equiv), CuBr (0.50 mmol, 10 mol %), and benzo\[*d*\]isoxazole **1a** (7.5 mmol, 1.5 equiv) were added to a solution of anhydrous DCE/DCM (10 mL, v/v = 1:1) at room temperature under N~2~. Then TEA (15 mmol, 3.0 equiv) was slowly added by a syringe. The reaction mixture was stirred at 80 °C for about 2--4 h. After completion of the reaction as indicated by TLC, the reaction mixture was quenched with saturated NH~4~Cl (30 mL), and extracted with ethyl acetate (30.0 mL × 3). The crude residue was purified by column chromatography (ethyl acetate/DCM, 1:20) to give the desired product **4a** (2.1 g, 94% yield) as a white solid.

General Procedure for the Hydrolysis of 2-Imino-2*H*-chromen-4-amine **4a** {#sec4.3}
---------------------------------------------------------------------------

To a screw-capped Schlenk tube 2-imino-2*H*-chromen-4-amine **4a** (0.30 mmol, 134 mg) and MeOH (0.5 mL) were added. Then H~2~SO~4~ (0.5 mL, 50% aqueous solution) was added at room temperature. The reaction mixture was heated to 100 °C and stirred overnight under N~2~. Upon completion, the reaction mixture was cooled down to room temperature, concentrated under vacuum to remove the volatile component. Then quenched with solid Na~2~CO~3~ to pH = 10. The reaction was extracted with ethyl acetate (5 mL × 3). The crude residue was purified by column chromatography to give the desired product **7** as a white solid (68.5 mg, 78% yield).

### 4-Amino-3-(4-butylphenyl)-2*H*-chromen-2-one **7** {#sec4.3.1}

Yield: 78%; white solid, mp: 154--155 °C. ^1^H NMR (400 MHz, CDCl~3~) δ: 7.58--7.50 (m, 2H), 7.32--7.22 (m, 6H), 5.21 (br, 2H), 2.60 (t, *J* = 8.0 Hz, 2H), 1.61--1.55 (m, 2H), 1.42--1.33 (m, 2H), 0.93 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~) δ: 162.4, 153.1, 150.2, 142.8, 131.7, 130.4, 129.9, 129.3, 123.6, 121.9, 117.4, 114.4, 100.6, 35.5, 33.5, 22.5, 14.0. HRMS calcd for C~19~H~19~N NaO~2~ (M + Na)^+^: 316.1313, found: 316.1308.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b01179](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b01179).^1^H, ^13^C NMR spectra and X-ray Oak Ridge thermal ellipsoid plot of **4d** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01179/suppl_file/ao8b01179_si_001.pdf))
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